Table 3.
Method | TGC-1 | TGC-2 | GP | ||
---|---|---|---|---|---|
Dataset | DLDA | k-NN | SVM | ||
Melanoma | 97 | 96 | 86 | 90 | 84 |
| |||||
Breast Cancer 1 | 64 | 64 | 74 | 60 | 68 |
| |||||
Brain Cancer | 77 | 75 | 67 | 63 | 67 |
| |||||
Breast Cancer 2 | 82 | 78 | 62 | 57 | 60 |
| |||||
Gastric Tumor | 89 | 88 | 80 | 77 | 81 |
| |||||
Lung Cancer 1 | 98 | 100 | 98 | 95 | 95 |
| |||||
Lung Cancer 2 | 93 | 93 | 86 | 89 | 91 |
| |||||
Lymphoma | 59 | 60 | 69 | 64 | 67 |
| |||||
Myeloma | 68 | 54 | 60 | 69 | 78 |
| |||||
Pancreatic Cancer | 71 | 73 | 78 | 76 | 73 |
| |||||
Prostate Cancer | 89 | 90 | 87 | 82 | 85 |